Cancer Patient Perspectives During COVID-19

Patient Perspectives in Breast Cancer Care During COVID-19

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05062538

Enrollment

Registered

2021-09-30

Start date

2020-08-24

Completion date

2024-07-15

Last updated

2024-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

COVID-19

Brief summary

Detailed description

A web-based survey will be emailed to all adult women diagnosed with invasive breast cancer or ductal carcinoma in situ who have been seen as surgical consultations within the last year (06/01/19-06/01/20). This will ensure that patients at various stages of treatment are included, from initial diagnosis into survivorship. This will allow the investigators to assess changes to initial consultations, surgeries, chemotherapy, and radiation, as well as patient perspectives as it relates to these changes. The web-based surveys will be given via Redcap. The study team will use a validated questionnaire developed at the University of Miami (Penedo, 2020), which includes a combination of multiple-choice questions, Likert scale ratings, and yes/no questions. A list of potential questions is listed below. A group of patients will be contacted for semi-structured interviews via telephone as well if (1) patients indicate willingness to participate on a separate RedCap survey or (2) if the patient does not respond to this survey. Phone interviews will be recorded and transcribed verbatim. Multiple members of the research team will separately code the information and evaluate for themes.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 60 Years

Healthy volunteers

Inclusion criteria

* Adult females with diagnosis of invasive breast cancer or ductal carcinoma in situ, seen as surgical consultation between 06/01/19-06/01/20

Exclusion criteria

* Males * Patients with non-cancer diagnoses * Patients with no history of breast cancer

Design outcomes

Primary

Measure	Time frame	Description
Number of participants with changes implemented to breast cancer treatment	12 months	Number of participants with changes implemented to breast cancer treatment during the COVID-19 pandemic
Number of participants with treatment concerns during COVID-19 pandemic	12 months	Patients with treatment concerns during the COVID-19 pandemic
Number of participants with effects of COVID-19 on psychological, social, and physical well-being of breast cancer patients	12 months	Number of participants with effects of COVID-19 on psychological, social, and physical well-being of breast cancer patients

Countries

United States

Outcome results